Literature DB >> 17018515

Thrombotic thrombocytopenic purpura masquerading as hemolysis, elevated liver enzymes, low platelets (HELLP) syndrome in late pregnancy.

Jonathan F Rehberg1, Christian M Briery, William T Hudson, James A Bofill, James N Martin.   

Abstract

BACKGROUND: Thrombotic thrombocytopenic purpura rarely presents during late pregnancy or immediately postpartum. This report describes the clinical course of a patient considered to have hemolysis, elevated liver enzymes, low platelets (HELLP) syndrome but later determined to have thrombotic thrombocytopenic purpura. CASE: At 37 weeks of gestation, a multiparous woman was diagnosed with HELLP syndrome. She received high-dose dexamethasone, magnesium, antihypertensives, and platelets before delivery. Over the next 36 hours, renal function acutely worsened and death ensued. One week after death a plasma ADAMTS13 activity of 4% was reported.
CONCLUSION: Thrombotic thrombocytopenic purpura can mimic HELLP syndrome late in gestation. Lack of response to dexamethasone within 12-24 hours and atypical relationships among laboratory values are two clues that thrombotic thrombocytopenic purpura may be the underlying pathology and that plasma exchange is emergently needed.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 17018515     DOI: 10.1097/01.AOG.0000215994.25958.31

Source DB:  PubMed          Journal:  Obstet Gynecol        ISSN: 0029-7844            Impact factor:   7.661


  6 in total

1.  Pregnancy-associated hemolytic uremic syndrome revisited in the era of complement gene mutations.

Authors:  Fadi Fakhouri; Lubka Roumenina; François Provot; Marion Sallée; Sophie Caillard; Lionel Couzi; Marie Essig; David Ribes; Marie-Agnès Dragon-Durey; Frank Bridoux; Eric Rondeau; Veronique Frémeaux-Bacchi
Journal:  J Am Soc Nephrol       Date:  2010-03-04       Impact factor: 10.121

2.  Alpha-hemoglobin-stabilizing protein (AHSP) in hemolysis, elevated liver enzyme, and low platelet (HELLP) syndrome, intrauterine growth restriction (IUGR) and fetal death.

Authors:  Monica Emanuelli; Davide Sartini; Valentina Rossi; Alessandra Corradetti; Beatrice Landi; Claudia Regina Vianna; Stefano Giannubilo; Andrea Luigi Tranquilli
Journal:  Cell Stress Chaperones       Date:  2008-02-06       Impact factor: 3.667

3.  Incidence of obstetrical thrombotic thrombocytopenic purpura in a retrospective study within thrombocytopenic pregnant women. A difficult diagnosis and a treatable disease.

Authors:  Yahsou Delmas; Sébastien Helou; Pierre Chabanier; Anne Ryman; Fanny Pelluard; Dominique Carles; Pierre Boisseau; Agnès Veyradier; Jacques Horovitz; Paul Coppo; Christian Combe
Journal:  BMC Pregnancy Childbirth       Date:  2015-06-17       Impact factor: 3.007

4.  A case report of undiagnosed postpartum hemolytic uremic syndrome.

Authors:  Jiao Mu; Ji Zhang; Ananda Sunnassee; Hongmei Dong
Journal:  Diagn Pathol       Date:  2015-07-08       Impact factor: 2.644

5.  Pregnancy-associated thrombotic thrombocytopenic purpura complicated by Sjögren's syndrome and non-neutralising antibodies to ADAMTS13: a case report.

Authors:  Lu Zhou; Yu Zhu; Miao Jiang; Min Su; Hong Liu; Jian Su; Xiaofan Liu; Yizhi Jiang; Hui Mu; Jie Yin; Li Yang; Haiyan Liu; Weidong Pan
Journal:  BMC Pregnancy Childbirth       Date:  2021-12-03       Impact factor: 3.007

6.  Diagnostic dilemma in a patient presenting with thrombotic microangiopathy in the setting of pregnancy.

Authors:  Mohamed Zakee Mohamed Jiffry; Mohammad Aimal Ahmed-Khan; Felipe Carmona Pires; Nkechi Okam; Mahnoor Hanif
Journal:  Arch Clin Cases       Date:  2022-04-06
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.